| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Integrins | 56 | 2019 | 839 | 4.650 |
Why?
|
| Antigens, CD | 53 | 2015 | 4031 | 4.360 |
Why?
|
| Receptors, Very Late Antigen | 41 | 1997 | 74 | 2.410 |
Why?
|
| Membrane Glycoproteins | 30 | 2012 | 3702 | 2.060 |
Why?
|
| Cell Adhesion | 59 | 2011 | 3093 | 1.900 |
Why?
|
| Membrane Proteins | 37 | 2015 | 7866 | 1.850 |
Why?
|
| Acyltransferases | 4 | 2020 | 305 | 1.740 |
Why?
|
| Integrin alpha6beta4 | 9 | 2013 | 30 | 1.710 |
Why?
|
| Integrin alpha3beta1 | 16 | 2010 | 53 | 1.390 |
Why?
|
| Antigens, Surface | 33 | 2004 | 1617 | 1.250 |
Why?
|
| Cell Adhesion Molecules | 25 | 2010 | 1612 | 1.110 |
Why?
|
| Membrane Microdomains | 6 | 2008 | 205 | 0.950 |
Why?
|
| Palmitic Acid | 5 | 2008 | 148 | 0.880 |
Why?
|
| Receptors, Lymphocyte Homing | 7 | 1997 | 141 | 0.720 |
Why?
|
| Fibronectins | 21 | 2009 | 722 | 0.720 |
Why?
|
| Laminin | 10 | 2019 | 404 | 0.720 |
Why?
|
| Integrin alpha6 | 2 | 2012 | 30 | 0.710 |
Why?
|
| Tumor Cells, Cultured | 31 | 2012 | 6105 | 0.690 |
Why?
|
| Lipoylation | 2 | 2012 | 87 | 0.670 |
Why?
|
| Platelet Membrane Glycoproteins | 7 | 2000 | 282 | 0.630 |
Why?
|
| Immunoglobulins | 5 | 2009 | 853 | 0.570 |
Why?
|
| Amino Acid Sequence | 42 | 2007 | 13410 | 0.570 |
Why?
|
| Protein Binding | 24 | 2011 | 9315 | 0.570 |
Why?
|
| Cell Line | 57 | 2008 | 15563 | 0.570 |
Why?
|
| Integrin alpha6beta1 | 5 | 2003 | 19 | 0.560 |
Why?
|
| Avian Proteins | 3 | 2004 | 77 | 0.540 |
Why?
|
| Cytoplasm | 12 | 2008 | 1505 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 53 | 2010 | 9243 | 0.500 |
Why?
|
| Molecular Sequence Data | 39 | 2007 | 17605 | 0.500 |
Why?
|
| Antigens, Neoplasm | 5 | 2004 | 1998 | 0.490 |
Why?
|
| Integrin alpha4beta1 | 9 | 2003 | 119 | 0.480 |
Why?
|
| Enzyme Stability | 2 | 2012 | 218 | 0.470 |
Why?
|
| Cysteine | 5 | 2007 | 898 | 0.460 |
Why?
|
| Cell Movement | 15 | 2015 | 5197 | 0.450 |
Why?
|
| Macromolecular Substances | 19 | 2004 | 1431 | 0.450 |
Why?
|
| Caveolins | 2 | 2004 | 102 | 0.440 |
Why?
|
| Kangai-1 Protein | 3 | 2011 | 22 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2013 | 2839 | 0.430 |
Why?
|
| Cricetinae | 17 | 2001 | 2416 | 0.430 |
Why?
|
| Cell Line, Tumor | 16 | 2020 | 17082 | 0.420 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 16 | 1997 | 692 | 0.420 |
Why?
|
| Antioxidants | 1 | 2020 | 1671 | 0.400 |
Why?
|
| Collagen | 14 | 2002 | 2634 | 0.400 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2004 | 147 | 0.400 |
Why?
|
| Protein Structure, Tertiary | 10 | 2011 | 3757 | 0.390 |
Why?
|
| Receptors, Immunologic | 15 | 1991 | 1418 | 0.390 |
Why?
|
| Extracellular Matrix | 12 | 2011 | 1729 | 0.390 |
Why?
|
| Precipitin Tests | 14 | 2002 | 816 | 0.390 |
Why?
|
| Blood Proteins | 3 | 2004 | 1192 | 0.370 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 3 | 2000 | 59 | 0.370 |
Why?
|
| Recombinant Fusion Proteins | 17 | 2004 | 3736 | 0.370 |
Why?
|
| ADAM Proteins | 2 | 2011 | 243 | 0.370 |
Why?
|
| Animals | 95 | 2017 | 168887 | 0.370 |
Why?
|
| Apoptosis | 5 | 2020 | 9507 | 0.360 |
Why?
|
| Antigens, Differentiation | 8 | 1989 | 921 | 0.360 |
Why?
|
| Cell Proliferation | 7 | 2017 | 10438 | 0.360 |
Why?
|
| beta Catenin | 2 | 2013 | 1047 | 0.350 |
Why?
|
| Manganese | 7 | 1998 | 393 | 0.350 |
Why?
|
| Neoplasm Metastasis | 5 | 2014 | 4888 | 0.340 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2010 | 183 | 0.330 |
Why?
|
| CHO Cells | 13 | 2001 | 1376 | 0.330 |
Why?
|
| Protein Conformation | 19 | 2005 | 3946 | 0.320 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 59 | 0.320 |
Why?
|
| Signal Transduction | 17 | 2015 | 23611 | 0.310 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2011 | 616 | 0.310 |
Why?
|
| RNA Interference | 6 | 2020 | 2825 | 0.310 |
Why?
|
| Transfection | 21 | 2002 | 5750 | 0.300 |
Why?
|
| T-Lymphocytes | 24 | 2003 | 10263 | 0.300 |
Why?
|
| Ligands | 14 | 2003 | 3276 | 0.300 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 21157 | 0.290 |
Why?
|
| Epitopes | 18 | 2002 | 2526 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2013 | 4049 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1997 | 0.270 |
Why?
|
| Oxidative Stress | 1 | 2017 | 3141 | 0.260 |
Why?
|
| Cross-Linking Reagents | 6 | 2007 | 689 | 0.260 |
Why?
|
| Camptothecin | 2 | 2020 | 599 | 0.260 |
Why?
|
| Mice, SCID | 3 | 2017 | 2626 | 0.260 |
Why?
|
| Cations, Divalent | 6 | 1998 | 167 | 0.250 |
Why?
|
| Adhesins, Bacterial | 2 | 1998 | 118 | 0.250 |
Why?
|
| Palmitates | 2 | 2004 | 68 | 0.250 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2011 | 1677 | 0.250 |
Why?
|
| Humans | 146 | 2020 | 766432 | 0.240 |
Why?
|
| Mice | 46 | 2017 | 81863 | 0.240 |
Why?
|
| Mice, Nude | 7 | 2017 | 3610 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1058 | 0.230 |
Why?
|
| Protein Interaction Mapping | 2 | 2007 | 621 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2012 | 2470 | 0.230 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2017 | 122 | 0.230 |
Why?
|
| Palmitic Acids | 1 | 2004 | 53 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 7 | 1980 | 319 | 0.230 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2009 | 461 | 0.220 |
Why?
|
| Neoplasms | 5 | 2019 | 22343 | 0.220 |
Why?
|
| Neoplasm Proteins | 6 | 2006 | 3601 | 0.220 |
Why?
|
| Receptors, Cell Surface | 7 | 2003 | 2815 | 0.220 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 1117 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5334 | 0.220 |
Why?
|
| Blotting, Western | 8 | 2012 | 5021 | 0.220 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13639 | 0.210 |
Why?
|
| Cell Membrane | 9 | 2006 | 3640 | 0.210 |
Why?
|
| Cell Membrane Structures | 1 | 2003 | 24 | 0.210 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 5860 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2009 | 1963 | 0.210 |
Why?
|
| Receptor, erbB-2 | 2 | 2012 | 2597 | 0.210 |
Why?
|
| Base Sequence | 15 | 2008 | 12412 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2799 | 0.200 |
Why?
|
| Cytoskeleton | 3 | 2006 | 1179 | 0.200 |
Why?
|
| Lymphocyte Activation | 16 | 1991 | 5502 | 0.200 |
Why?
|
| Kidney Diseases | 1 | 2013 | 2101 | 0.200 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 2001 | 897 | 0.190 |
Why?
|
| Enterovirus B, Human | 4 | 1994 | 49 | 0.190 |
Why?
|
| Molecular Weight | 18 | 1996 | 2168 | 0.190 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4270 | 0.190 |
Why?
|
| Neoplasm Transplantation | 4 | 2015 | 2010 | 0.180 |
Why?
|
| Receptors, Fibronectin | 9 | 1996 | 37 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2629 | 0.180 |
Why?
|
| Cell Aggregation | 5 | 1993 | 238 | 0.180 |
Why?
|
| Integrin alpha4 | 7 | 1997 | 89 | 0.180 |
Why?
|
| Cell Size | 2 | 2002 | 626 | 0.180 |
Why?
|
| Cloning, Molecular | 9 | 2005 | 4167 | 0.170 |
Why?
|
| Sequence Deletion | 7 | 2002 | 1494 | 0.170 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 300 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2012 | 8300 | 0.170 |
Why?
|
| Plant Oils | 1 | 2000 | 199 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 3 | 1993 | 833 | 0.170 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1206 | 0.160 |
Why?
|
| Receptors, Collagen | 7 | 1995 | 25 | 0.160 |
Why?
|
| Flow Cytometry | 17 | 2012 | 5890 | 0.160 |
Why?
|
| Receptors, Virus | 4 | 1999 | 652 | 0.160 |
Why?
|
| Enzyme Activation | 5 | 2010 | 3585 | 0.150 |
Why?
|
| Dimerization | 3 | 2005 | 882 | 0.150 |
Why?
|
| Integrin alpha Chains | 3 | 2012 | 93 | 0.150 |
Why?
|
| Neurites | 1 | 2000 | 389 | 0.150 |
Why?
|
| K562 Cells | 3 | 2011 | 645 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 4 | 2015 | 3608 | 0.150 |
Why?
|
| Cells, Cultured | 12 | 2011 | 18979 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 4400 | 0.150 |
Why?
|
| Rhabdomyosarcoma | 4 | 1996 | 358 | 0.150 |
Why?
|
| Prostaglandins | 4 | 1980 | 398 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2001 | 562 | 0.140 |
Why?
|
| Mutagenesis | 2 | 2001 | 1228 | 0.140 |
Why?
|
| 3T3 Cells | 4 | 2003 | 1082 | 0.140 |
Why?
|
| Leukocytes | 4 | 1995 | 2033 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2005 | 2746 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2210 | 0.140 |
Why?
|
| Integrin alpha3 | 4 | 2001 | 26 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 1999 | 4924 | 0.140 |
Why?
|
| Magnesium | 3 | 1995 | 815 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 1999 | 1324 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 2 | 2011 | 423 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2001 | 1227 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1602 | 0.130 |
Why?
|
| Melanoma | 1 | 2015 | 5699 | 0.130 |
Why?
|
| Structure-Activity Relationship | 7 | 1997 | 3053 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 661 | 0.130 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1995 | 825 | 0.120 |
Why?
|
| Peptide Fragments | 7 | 2002 | 5129 | 0.120 |
Why?
|
| Recombinant Proteins | 8 | 1998 | 6507 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2000 | 1729 | 0.120 |
Why?
|
| Proteins | 4 | 2008 | 6002 | 0.120 |
Why?
|
| Transplantation, Heterologous | 3 | 2015 | 2391 | 0.120 |
Why?
|
| Receptors, Laminin | 5 | 1995 | 26 | 0.120 |
Why?
|
| Kinetics | 10 | 1996 | 6285 | 0.120 |
Why?
|
| Dioxoles | 1 | 2015 | 96 | 0.120 |
Why?
|
| Octoxynol | 3 | 2002 | 76 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 434 | 0.120 |
Why?
|
| Multigene Family | 3 | 2000 | 1081 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3424 | 0.120 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1996 | 429 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 1999 | 4966 | 0.110 |
Why?
|
| Cell Line, Transformed | 3 | 2012 | 861 | 0.110 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2012 | 100 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 4521 | 0.110 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2015 | 199 | 0.110 |
Why?
|
| Binding Sites | 7 | 2003 | 6010 | 0.110 |
Why?
|
| Integrin beta Chains | 1 | 1994 | 116 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2001 | 2900 | 0.110 |
Why?
|
| Receptors, Peptide | 2 | 1996 | 280 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2009 | 3458 | 0.110 |
Why?
|
| Enzyme Induction | 2 | 2004 | 455 | 0.110 |
Why?
|
| Proteomics | 1 | 2007 | 3906 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 304 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 1997 | 562 | 0.110 |
Why?
|
| Frizzled Receptors | 1 | 2013 | 86 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2012 | 14466 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 1988 | 1027 | 0.100 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1998 | 176 | 0.100 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 58 | 0.100 |
Why?
|
| Fibroblasts | 6 | 2012 | 4164 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2012 | 12 | 0.100 |
Why?
|
| Peroxides | 4 | 1980 | 76 | 0.100 |
Why?
|
| Chromatography, Liquid | 2 | 2007 | 996 | 0.100 |
Why?
|
| Caveolin 1 | 2 | 2004 | 255 | 0.100 |
Why?
|
| Mutation | 11 | 2011 | 30220 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 8 | 1996 | 3407 | 0.100 |
Why?
|
| Fibrosarcoma | 3 | 2001 | 313 | 0.100 |
Why?
|
| Receptors, Antigen | 2 | 1989 | 51 | 0.100 |
Why?
|
| Transcellular Cell Migration | 1 | 2011 | 3 | 0.100 |
Why?
|
| Models, Biological | 6 | 2008 | 9458 | 0.090 |
Why?
|
| U937 Cells | 1 | 2011 | 259 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2002 | 11648 | 0.090 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2011 | 106 | 0.090 |
Why?
|
| Glycoproteins | 3 | 1993 | 2201 | 0.090 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 928 | 0.090 |
Why?
|
| HeLa Cells | 4 | 2009 | 3072 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 11919 | 0.090 |
Why?
|
| Carcinogens | 1 | 2012 | 452 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2005 | 1159 | 0.080 |
Why?
|
| Peptides | 5 | 1998 | 4344 | 0.080 |
Why?
|
| Calcium | 4 | 1995 | 5781 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 496 | 0.080 |
Why?
|
| Glycosylation | 2 | 2004 | 1100 | 0.080 |
Why?
|
| Extracellular Space | 2 | 2002 | 562 | 0.080 |
Why?
|
| Epidermal Growth Factor | 2 | 2012 | 697 | 0.080 |
Why?
|
| Solubility | 3 | 1998 | 1078 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1697 | 0.080 |
Why?
|
| Seminal Vesicles | 3 | 1978 | 101 | 0.080 |
Why?
|
| Benzamides | 1 | 2015 | 1375 | 0.080 |
Why?
|
| Integrin beta4 | 2 | 2001 | 29 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2884 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2008 | 120 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1494 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 1998 | 3833 | 0.080 |
Why?
|
| Disulfides | 2 | 2005 | 462 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 504 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 526 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 872 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 1988 | 110 | 0.070 |
Why?
|
| Transgenes | 1 | 2011 | 1014 | 0.070 |
Why?
|
| Melanoma, Experimental | 1 | 2011 | 556 | 0.070 |
Why?
|
| Oligopeptides | 4 | 1995 | 1195 | 0.070 |
Why?
|
| Antigens | 2 | 1984 | 1441 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 22337 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2005 | 5385 | 0.070 |
Why?
|
| Jurkat Cells | 2 | 2001 | 739 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2393 | 0.070 |
Why?
|
| Blotting, Northern | 5 | 1992 | 1549 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2007 | 2196 | 0.070 |
Why?
|
| Quinazolines | 2 | 2012 | 1367 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1505 | 0.070 |
Why?
|
| Mammary Glands, Human | 1 | 2008 | 201 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2019 | 12788 | 0.070 |
Why?
|
| Cell Communication | 2 | 2008 | 1658 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2002 | 1646 | 0.070 |
Why?
|
| B-Lymphocytes | 4 | 1992 | 4784 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2012 | 1335 | 0.070 |
Why?
|
| Integrin alpha2 | 2 | 1997 | 39 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 960 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3576 | 0.060 |
Why?
|
| Cricetulus | 2 | 2001 | 810 | 0.060 |
Why?
|
| Phytohemagglutinins | 4 | 1987 | 164 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2010 | 1755 | 0.060 |
Why?
|
| Neutrophils | 1 | 1998 | 3782 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2005 | 873 | 0.060 |
Why?
|
| Ethylmaleimide | 1 | 2005 | 69 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 2 | 1977 | 265 | 0.060 |
Why?
|
| Actins | 2 | 2006 | 2060 | 0.060 |
Why?
|
| Genes | 1 | 1989 | 1824 | 0.060 |
Why?
|
| Binding, Competitive | 4 | 1991 | 1141 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 1991 | 2570 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2008 | 2275 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 5 | 1987 | 564 | 0.060 |
Why?
|
| Cell Division | 6 | 1999 | 4474 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 1672 | 0.060 |
Why?
|
| Molecular Conformation | 2 | 2005 | 540 | 0.060 |
Why?
|
| Amino Sugars | 1 | 2004 | 39 | 0.060 |
Why?
|
| Binding Sites, Antibody | 4 | 1995 | 340 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2176 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 1998 | 1657 | 0.060 |
Why?
|
| DNA | 9 | 1993 | 7207 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2004 | 120 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 1986 | 391 | 0.060 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 324 | 0.060 |
Why?
|
| Leucine | 1 | 2005 | 547 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 2930 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2005 | 366 | 0.050 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 102 | 0.050 |
Why?
|
| Blood Platelets | 5 | 1988 | 2465 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 2003 | 455 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 505 | 0.050 |
Why?
|
| Immunosorbent Techniques | 3 | 1988 | 174 | 0.050 |
Why?
|
| Protein Transport | 1 | 2009 | 1940 | 0.050 |
Why?
|
| Gene Expression | 3 | 2012 | 7583 | 0.050 |
Why?
|
| Interleukin-2 | 3 | 1985 | 1894 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2004 | 148 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11094 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2006 | 640 | 0.050 |
Why?
|
| Prostaglandins G | 2 | 1979 | 2 | 0.050 |
Why?
|
| Thymus Gland | 4 | 1995 | 1260 | 0.050 |
Why?
|
| Mycoplasma | 1 | 1982 | 146 | 0.050 |
Why?
|
| Lysosomes | 1 | 2008 | 937 | 0.050 |
Why?
|
| Mycoplasma Infections | 1 | 1982 | 120 | 0.050 |
Why?
|
| Gels | 2 | 1995 | 420 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 68 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 8619 | 0.050 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2001 | 46 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2004 | 405 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2004 | 540 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 4114 | 0.050 |
Why?
|
| Isoelectric Focusing | 4 | 1988 | 148 | 0.050 |
Why?
|
| DNA Primers | 2 | 2008 | 2824 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 187 | 0.050 |
Why?
|
| COS Cells | 2 | 2001 | 1135 | 0.050 |
Why?
|
| Fertilization | 1 | 2003 | 197 | 0.050 |
Why?
|
| Glycine | 1 | 2005 | 671 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 391 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 663 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 297 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 594 | 0.050 |
Why?
|
| Endopeptidases | 3 | 1994 | 762 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2002 | 241 | 0.050 |
Why?
|
| Benzophenanthridines | 1 | 2001 | 27 | 0.050 |
Why?
|
| Exocytosis | 1 | 2003 | 323 | 0.050 |
Why?
|
| Phenanthridines | 1 | 2001 | 50 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2003 | 265 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 940 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 456 | 0.050 |
Why?
|
| Goats | 1 | 2001 | 166 | 0.050 |
Why?
|
| Genistein | 1 | 2001 | 87 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2675 | 0.050 |
Why?
|
| Astrocytes | 1 | 2009 | 1351 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 814 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3466 | 0.040 |
Why?
|
| Rats | 4 | 1998 | 23718 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3605 | 0.040 |
Why?
|
| Magnetics | 1 | 2003 | 585 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1988 | 0.040 |
Why?
|
| Staurosporine | 1 | 2001 | 241 | 0.040 |
Why?
|
| Disease Progression | 2 | 2008 | 13632 | 0.040 |
Why?
|
| Polyethylene Glycols | 2 | 2000 | 1189 | 0.040 |
Why?
|
| Growth Cones | 1 | 2000 | 117 | 0.040 |
Why?
|
| Alkaloids | 1 | 2001 | 192 | 0.040 |
Why?
|
| Desmin | 1 | 1999 | 99 | 0.040 |
Why?
|
| Dystroglycans | 1 | 1999 | 62 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2001 | 2678 | 0.040 |
Why?
|
| Prostaglandin Endoperoxides | 1 | 1978 | 12 | 0.040 |
Why?
|
| Female | 12 | 2020 | 396354 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2006 | 1342 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 839 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 238 | 0.040 |
Why?
|
| Giant Cells | 1 | 1999 | 187 | 0.040 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 1998 | 15 | 0.040 |
Why?
|
| Cell Fusion | 1 | 1999 | 294 | 0.040 |
Why?
|
| Yersinia | 1 | 1998 | 9 | 0.040 |
Why?
|
| Molecular Structure | 2 | 1996 | 1881 | 0.040 |
Why?
|
| Titrimetry | 1 | 1998 | 36 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11217 | 0.040 |
Why?
|
| Plasmids | 2 | 2002 | 2267 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2002 | 806 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 484 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1989 | 259 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 1056 | 0.040 |
Why?
|
| Schwann Cells | 1 | 1999 | 195 | 0.040 |
Why?
|
| Time Factors | 6 | 2003 | 40116 | 0.040 |
Why?
|
| Sodium Azide | 1 | 1997 | 24 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 1999 | 479 | 0.040 |
Why?
|
| EF Hand Motifs | 1 | 1997 | 19 | 0.040 |
Why?
|
| Dystrophin | 1 | 1999 | 283 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2002 | 743 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 1109 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 1995 | 300 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2004 | 1020 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 2083 | 0.040 |
Why?
|
| Cytochalasin B | 1 | 1997 | 74 | 0.040 |
Why?
|
| Leukemia, Experimental | 2 | 1996 | 224 | 0.040 |
Why?
|
| Trypsin | 2 | 1988 | 490 | 0.030 |
Why?
|
| Receptor Aggregation | 1 | 1997 | 72 | 0.030 |
Why?
|
| Serine | 1 | 2001 | 829 | 0.030 |
Why?
|
| Heme | 4 | 1980 | 316 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 1999 | 399 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1982 | 1477 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1749 | 0.030 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 1996 | 49 | 0.030 |
Why?
|
| Temperature | 1 | 2003 | 2229 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1998 | 380 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1990 | 1802 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2062 | 0.030 |
Why?
|
| Chemical Precipitation | 4 | 1984 | 174 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 1245 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1997 | 276 | 0.030 |
Why?
|
| Mammals | 1 | 2001 | 1134 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2006 | 1595 | 0.030 |
Why?
|
| Interphase | 2 | 1988 | 226 | 0.030 |
Why?
|
| Antibody Specificity | 3 | 1995 | 1062 | 0.030 |
Why?
|
| Endothelium, Vascular | 4 | 1995 | 4417 | 0.030 |
Why?
|
| Integrin alpha5 | 1 | 1995 | 20 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2002 | 2078 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1996 | 419 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1998 | 637 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1996 | 425 | 0.030 |
Why?
|
| Phylogeny | 1 | 2003 | 2839 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 1995 | 364 | 0.030 |
Why?
|
| Lung | 3 | 2012 | 10064 | 0.030 |
Why?
|
| Kidney | 2 | 2005 | 7071 | 0.030 |
Why?
|
| Digitonin | 1 | 1994 | 25 | 0.030 |
Why?
|
| Ionomycin | 1 | 1994 | 109 | 0.030 |
Why?
|
| Homeostasis | 2 | 2012 | 3341 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1995 | 286 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1994 | 165 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1991 | 524 | 0.030 |
Why?
|
| Hematopoiesis | 2 | 1995 | 2060 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4779 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2668 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29922 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1998 | 761 | 0.030 |
Why?
|
| Antibodies | 4 | 2004 | 2421 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 663 | 0.030 |
Why?
|
| Vitronectin | 1 | 1993 | 40 | 0.030 |
Why?
|
| Calpain | 1 | 1994 | 146 | 0.030 |
Why?
|
| Chickens | 1 | 1995 | 842 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5696 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1983 | 341 | 0.030 |
Why?
|
| Point Mutation | 1 | 1998 | 1591 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 1742 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 705 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 891 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 1980 | 361 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 2477 | 0.030 |
Why?
|
| Butadienes | 1 | 2012 | 107 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2001 | 1475 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2012 | 120 | 0.020 |
Why?
|
| Male | 11 | 2020 | 363975 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2880 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 10860 | 0.020 |
Why?
|
| Chemotaxis | 1 | 1995 | 598 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2012 | 91 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13486 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2012 | 144 | 0.020 |
Why?
|
| Sequence Homology | 1 | 1992 | 197 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2426 | 0.020 |
Why?
|
| Cholesterol | 1 | 2000 | 2903 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2012 | 146 | 0.020 |
Why?
|
| Cell Survival | 2 | 1994 | 5741 | 0.020 |
Why?
|
| Self Tolerance | 1 | 2012 | 119 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 1991 | 120 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 1992 | 363 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 491 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 6 | 1992 | 6217 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 848 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1986 | 3788 | 0.020 |
Why?
|
| Drosophila | 1 | 1998 | 1507 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 273 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1992 | 645 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 1947 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1132 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 545 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3721 | 0.020 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 2 | 1989 | 20 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11059 | 0.020 |
Why?
|
| Receptors, Transferrin | 2 | 1992 | 300 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1994 | 1077 | 0.020 |
Why?
|
| Pericytes | 1 | 2012 | 298 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 541 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 76 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 212 | 0.020 |
Why?
|
| Glutathione Peroxidase | 2 | 1980 | 258 | 0.020 |
Why?
|
| Clone Cells | 5 | 1984 | 1670 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9611 | 0.020 |
Why?
|
| Organ Specificity | 2 | 1991 | 1966 | 0.020 |
Why?
|
| Arachidonic Acids | 2 | 1980 | 295 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3400 | 0.020 |
Why?
|
| Placenta | 2 | 1988 | 1725 | 0.020 |
Why?
|
| Cholic Acids | 1 | 1987 | 39 | 0.020 |
Why?
|
| Lipids | 1 | 1979 | 3319 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1993 | 685 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 1103 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1991 | 960 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1989 | 512 | 0.020 |
Why?
|
| Blood | 2 | 1988 | 597 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 1243 | 0.020 |
Why?
|
| Epithelium | 2 | 1989 | 1606 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 2629 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1999 | 3689 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6061 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 981 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 1997 | 4559 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2012 | 1251 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 12147 | 0.020 |
Why?
|
| Sheep | 2 | 1980 | 1448 | 0.020 |
Why?
|
| Chemistry | 2 | 1983 | 327 | 0.020 |
Why?
|
| Phenols | 2 | 1980 | 526 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1983 | 485 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 610 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1993 | 1801 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 2094 | 0.020 |
Why?
|
| Glycoside Hydrolases | 1 | 1985 | 135 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 162 | 0.020 |
Why?
|
| Artifacts | 1 | 1994 | 1896 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1994 | 2446 | 0.020 |
Why?
|
| Rabbits | 3 | 1987 | 4752 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1992 | 2413 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1978 | 539 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 14071 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1984 | 98 | 0.010 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2004 | 34 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 2004 | 109 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2006 | 492 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3795 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1985 | 387 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10740 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1994 | 2901 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1992 | 4141 | 0.010 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1982 | 52 | 0.010 |
Why?
|
| Isoantigens | 1 | 1985 | 562 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1982 | 108 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1982 | 122 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1988 | 534 | 0.010 |
Why?
|
| Cattle | 2 | 1994 | 3814 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 27156 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1983 | 1352 | 0.010 |
Why?
|
| Encephalitis | 1 | 1985 | 440 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2006 | 871 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1982 | 250 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1982 | 261 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1987 | 1675 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1982 | 330 | 0.010 |
Why?
|
| Sodium Cyanide | 1 | 1980 | 9 | 0.010 |
Why?
|
| Neurons | 1 | 2000 | 9515 | 0.010 |
Why?
|
| Naphthols | 1 | 1980 | 46 | 0.010 |
Why?
|
| Apoproteins | 1 | 1980 | 45 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1980 | 112 | 0.010 |
Why?
|
| Free Radicals | 1 | 1980 | 237 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1980 | 241 | 0.010 |
Why?
|
| Catalase | 1 | 1980 | 215 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1982 | 1339 | 0.010 |
Why?
|
| Prostaglandins H | 1 | 1978 | 23 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4498 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3803 | 0.010 |
Why?
|
| Antibody Formation | 2 | 1981 | 1392 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1987 | 1266 | 0.010 |
Why?
|
| Catalysis | 1 | 1980 | 767 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1983 | 1441 | 0.010 |
Why?
|
| Iron | 2 | 1977 | 1812 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1985 | 1366 | 0.010 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1977 | 64 | 0.010 |
Why?
|
| Carcinoma | 1 | 1989 | 2323 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1982 | 1148 | 0.010 |
Why?
|
| Apoenzymes | 1 | 1976 | 14 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1989 | 2533 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 7436 | 0.010 |
Why?
|
| DNA Replication | 1 | 1984 | 1426 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1980 | 560 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1976 | 199 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1976 | 291 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1999 | 572 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1990 | 6612 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 2185 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1980 | 1442 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1979 | 2223 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1983 | 511 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18322 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1992 | 152 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1982 | 421 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1992 | 317 | 0.010 |
Why?
|
| Monocytes | 1 | 1981 | 2599 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 281 | 0.010 |
Why?
|
| Myeloma Proteins | 2 | 1981 | 71 | 0.010 |
Why?
|
| Immune Sera | 2 | 1981 | 605 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1985 | 3229 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1992 | 656 | 0.010 |
Why?
|
| Pregnancy | 2 | 1990 | 30235 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1990 | 423 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1989 | 66 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 354 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.000 |
Why?
|
| Chromosome Mapping | 2 | 1984 | 4618 | 0.000 |
Why?
|
| Pulmonary Alveoli | 1 | 1988 | 665 | 0.000 |
Why?
|
| Blood Cells | 1 | 1987 | 308 | 0.000 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 1984 | 26 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1984 | 69 | 0.000 |
Why?
|
| Karyotyping | 1 | 1984 | 1176 | 0.000 |
Why?
|
| Hybridomas | 1 | 1982 | 442 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1981 | 307 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1983 | 609 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1980 | 152 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1982 | 726 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1982 | 825 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1981 | 527 | 0.000 |
Why?
|
| Growth Substances | 1 | 1980 | 759 | 0.000 |
Why?
|
| Lipoxygenase | 1 | 1977 | 72 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1984 | 2603 | 0.000 |
Why?
|
| Malondialdehyde | 1 | 1977 | 113 | 0.000 |
Why?
|
| Isoantibodies | 1 | 1980 | 681 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1981 | 1079 | 0.000 |
Why?
|
| Platelet Aggregation | 1 | 1977 | 769 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1981 | 2605 | 0.000 |
Why?
|
| Leukemia | 1 | 1981 | 1521 | 0.000 |
Why?
|
| Smoking | 1 | 1988 | 9076 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1981 | 3113 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1981 | 3635 | 0.000 |
Why?
|
| Aging | 1 | 1983 | 8725 | 0.000 |
Why?
|
| Infant | 1 | 1983 | 36460 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1983 | 42576 | 0.000 |
Why?
|
| Child | 1 | 1983 | 80668 | 0.000 |
Why?
|
| Adolescent | 1 | 1983 | 88898 | 0.000 |
Why?
|
| Middle Aged | 1 | 1983 | 223127 | 0.000 |
Why?
|
| Adult | 1 | 1983 | 223253 | 0.000 |
Why?
|